|
1
|
Ferenci P, Fried M, Labrecque D, Bruix J,
Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA,
et al: World gastroenterology organisation global guideline.
Hepatocellular carcinoma (hcc): A global perspective. J
Gastrointestin Liver Dis. 19:311–317. 2010.PubMed/NCBI
|
|
2
|
Nordenstedt H, White DL and El-Serag HB:
The changing pattern of epidemiology in hepatocellular carcinoma.
Dig Liver Dis. 42(Suppl 3): S206–S214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greer SN, Metcalf JL, Wang Y and Ohh M:
The updated biology of hypoxia-inducible factor. EMBO J.
31:2448–2460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu XZ, Xie GR and Chen D: Hypoxia and
hepatocellular carcinoma: The therapeutic target for hepatocellular
carcinoma. J Gastroenterol Hepatol. 22:1178–1182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Semenza GL: Hypoxia-inducible factor 1
(HIF-1) pathway. Sci STKE. 2007:cm82007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1)alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koeppen M, Eckle T and Eltzschig HK: The
hypoxia-inflammation link and potential drug targets. Curr Opin
Anaesthesiol. 24:363–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beutler B: Tlr4: Central component of the
sole mammalian LPS sensor. Curr Opin Immunol. 12:20–26. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dhupar R, Klune JR, Evankovich J, Cardinal
J, Zhang M, Ross M, Murase N, Geller DA, Billiar TR and Tsung A:
Interferon regulatory factor 1 mediates acetylation and release of
high mobility group box 1 from hepatocytes during murine liver
ischemia-reperfusion injury. Shock. 35:293–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cario E and Podolsky DK: Differential
alteration in intestinal epithelial cell expression of Toll-like
receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect
Immun. 68:7010–7017. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edfeldt K, Swedenborg J, Hansson GK and
Yan ZQ: Expression of toll-like receptors in human atherosclerotic
lesions: A possible pathway for plaque activation. Circulation.
105:1158–1161. 2002.PubMed/NCBI
|
|
12
|
Lall H, Coughlan K and Sumbayev VV:
HIF-1alpha protein is an essential factor for protection of myeloid
cells against LPS-induced depletion of ATP and apoptosis that
supports toll-like receptor 4-mediated production of IL-6. Mol
Immunol. 45:3045–3049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peyssonnaux C, Cejudo-Martin P, Doedens A,
Zinkernagel AS, Johnson RS and Nizet V: Cutting edge: Essential
role of hypoxia inducible factor-1alpha in development of
lipopolysaccharide-induced sepsis. J Immunol. 178:7516–7519. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sumbayev VV: LPS-induced toll-like
receptor 4 signalling triggers cross-talk of apoptosis
signal-regulating kinase 1 (ASK1) and HIF-1alpha protein. FEBS
Lett. 582:319–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsuzawa A, Saegusa K, Noguchi T,
Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K
and Ichijo H: ROS-dependent activation of the TRAF6-ASK1-p38
pathway is selectively required for TLR4-mediated innate immunity.
Nat Immunol. 6:587–592. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Daoud A, Song J, Xiao F and Shang J:
B-9-3, a novel β-carboline derivative exhibits anti-cancer activity
via induction of apoptosis and inhibition of cell migration in
vitro. Eur J Pharmacol. 724:219–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng W, Liu P, Pan W, Singh SR and Wei Y:
Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer
Lett. 356:263–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Semenza GL: HIF-1 mediates metabolic
responses to intratumoral hypoxia and oncogenic mutations. J Clin
Invest. 123:3664–3671. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Onishi H, Morisaki T, Nakao F, Odate S,
Morisaki T and Katano M: Protein-bound polysaccharide decreases
invasiveness and proliferation in pancreatic cancer by inhibition
of hedgehog signaling and HIF-1α pathways under hypoxia. Cancer
Lett. 335:289–298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pugh CW and Ratcliffe PJ: Regulation of
angiogenesis by hypoxia: Role of the HIF system. Nat Med.
9:677–684. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl
Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Xu R, Feng L, Guo W, Cao N, Qian C,
Teng P, Wang L, Wu X, Sun Y, et al: A novel chromone derivative
with anti-inflammatory property via inhibition of ROS-dependent
activation of TRAF6-ASK1-p38 pathway. PloS One. 7:e371682012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grabinski N, Bartkowiak K, Grupp K, Brandt
B, Pantel K and Jücker M: Distinct functional roles of Akt isoforms
for proliferation, survival, migration and EGF-mediated signalling
in lung cancer derived disseminated tumor cells. Cell Signal.
23:1952–1960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamaguchi R, Yano H, Iemura A, Ogasawara
S, Haramaki M and Kojiro M: Expression of vascular endothelial
growth factor in human hepatocellular carcinoma. Hepatology.
28:68–77. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soufla G, Sifakis S and Spandidos DA: FGF2
transcript levels are positively correlated with EGF and IGF-1 in
the malignant endometrium. Cancer Lett. 259:146–155. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jensen RL, Ragel BT, Whang K and Gillespie
D: Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases
vascular endothelial growth factor (VEGF) secretion and tumor
growth in malignant gliomas. J Neurooncol. 78:233–247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Neill LA and Bowie AG: The family of
five: TIR-domain-containing adaptors in toll-like receptor
signalling. Nat Rev Immunol. 7:353–364. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Spirig R, Djafarzadeh S, Regueira T, Shaw
SG, von Garnier C, Takala J, Jakob SM, Rieben R and Lepper PM:
Effects of TLR agonists on the hypoxia-regulated transcription
factor HIF-1alpha and dendritic cell maturation under normoxic
conditions. PloS One. 5:e00109832010. View Article : Google Scholar : PubMed/NCBI
|
